按反应进行的结果分析存在缺陷。 - Suppr

Analysis of outcome by response flawed.

作者信息

Anderson James R, Neuberg Donna S

出版信息

J Clin Oncol. 2005 Nov 1;23(31):8122-3; author reply 8123-4. doi: 10.1200/JCO.2005.03.0148.

DOI:10.1200/JCO.2005.03.0148

PMID:16258114

Abstract

摘要

相似文献

Analysis of outcome by response flawed.

J Clin Oncol. 2005 Nov 1;23(31):8122-3; author reply 8123-4. doi: 10.1200/JCO.2005.03.0148.

Treatment of chronic lymphocytic leukemia: achieving minimal residual disease-negative status as a goal.

J Clin Oncol. 2005 May 1;23(13):2884-5. doi: 10.1200/JCO.2005.11.932. Epub 2005 Feb 28.

Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.

Clin Adv Hematol Oncol. 2008 Oct;6(10):727-9.

Chronic lymphocytic leukemia presenting in association with aplastic anemia.

Am J Hematol. 2002 Dec;71(4):323-7. doi: 10.1002/ajh.10226.

Chronic lymphocytic leukemia: a niche for flavopiridol?

Clin Cancer Res. 2005 Jun 1;11(11):3971-3. doi: 10.1158/1078-0432.CCR-05-0831.

Importance of minimal residual disease testing during the second year of disease: still no answer?

J Clin Oncol. 2003 Dec 1;21(23):4463-4; author reply 4464-5. doi: 10.1200/JCO.2003.99.093.

New drugs for chronic lymphocytic leukemia.

Clin Adv Hematol Oncol. 2006 Mar;4(3):183-5.

A comparison of the sensitivity of flow cytometry and bone marrow biopsy in the detection of minimal residual disease in chronic lymphocytic leukemia.

Haematologica. 2006 Jun;91(6):860-1.

Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.

Clin Cancer Res. 2008 Jan 1;14(1):155-61. doi: 10.1158/1078-0432.CCR-07-1371.

Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.

Clin Exp Dermatol. 2007 Mar;32(2):151-4. doi: 10.1111/j.1365-2230.2006.02324.x. Epub 2007 Jan 18.

引用本文的文献

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Sci Transl Med. 2016 Nov 9;8(364):364ra155. doi: 10.1126/scitranslmed.aai8545.

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.

Haematologica. 2014 May;99(5):873-80. doi: 10.3324/haematol.2013.099796. Epub 2014 Apr 3.

Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation.

Haematologica. 2009 May;94(5):654-62. doi: 10.3324/haematol.2008.000273. Epub 2009 Apr 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Analysis of outcome by response flawed.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献